Abstract
This paper records an attempt to assess the prophylactic value of immune gamma-globulin, prepared from the serum of recently vaccinated adults, in the protection of close contacts of smallpox in Madras. The results serve to confirm findings of a previous study made in Madras in 1953, and show that the incidence of smallpox in close contacts given immune gamma-globulin prophylactically was about a quarter of that in the control contacts who received no such passive immunization—a statistically significant difference. Because of the limited supply of immune gamma-globulin, it is likely that its prophylactic use will be restricted to those especially at risk, for example, close unvaccinated family contacts, newborn infants and pregnant women.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- KEMPE C. H., BERGE T. O., ENGLAND B. Hyperimmune vaccinal gamma globulin; source, evaluation, and use in prophylaxis and therapy. Pediatrics. 1956 Aug;18(2):177–188. [PubMed] [Google Scholar]
- KEMPE C. H., BERGE T. O., ENGLAND B. Hyperimmune vaccinal gamma globulin; source, evaluation, and use in prophylaxis and therapy. Pediatrics. 1956 Aug;18(2):177–188. [PubMed] [Google Scholar]
- KEMPE C. H. Studies smallpox and complications of smallpox vaccination. Pediatrics. 1960 Aug;26:176–189. [PubMed] [Google Scholar]
- KEMPE C. H. Studies smallpox and complications of smallpox vaccination. Pediatrics. 1960 Aug;26:176–189. [PubMed] [Google Scholar]